Business Cases and Advantages of eCTD v4.0

Slides:



Advertisements
Similar presentations
© 2011 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Advertisements

1 Future strategy for e-submission as seen by industry Dr Michael Colmorgen, IFAH-Europe 2nd Veterinary Workshop on E-submission 4 Dec 2009, EMEA, London.
ITIL: Service Transition
Dr Gordon Russell, Napier University Unit Data Dictionary 1 Data Dictionary Unit 5.3.
©2014 Factorytalk Co., Ltd. Proprietary and Confidential eCTD Specification 17 July 2014.
RPS WG Update March 2015 Open Stakeholder Session Nancy Shadeed Health Canada.
EFPIA EFPIA IT Proposals ppt Slide 1 EFPIA Proposals for IT Support to the European Regulatory Procedures Mr S. Hasler EFPIA PAT Regulation 2000.
Justina A. Molzon, MS Pharm, JD
ICH V1 An FDA Update Min Chen, M.S., RPh Office of Drug Safety Center for Drug Evaluation and Research FDA January 21, 2003.
Maintenance and operation of the data catalog (portal site) Second half of FY 2013 FY 2014 Organize and present views on releasing data of local public.
IRISS Lifecycle Group Joe Cipollina – Pfizer Ted Hanebach – canreg Shy Kumar – Datafarm Inc. Alastair Nixon – GlaxoSmithKline Kevin Wing - eCTDConsultancy.
DMF Procedures and Communication between API, FP Manufacturers and Regulatory Authorities Jean-Louis ROBERT National Health Laboratory L – 1011 LUXEMBOURG.
ISO 9001:2008 to ISO 9001:2015 Summary of Changes
DEPARTMENT OF HEALTH Medicines Regulatory Affairs
Best Archival Practice in the Regulation of Medicines: Work on the Guidelines for Agencies for Medicinal Products Ph.D. Arian Rajh Agency for Medicinal.
Recommendation 2001/331/EC: Review and relation to sectoral inspection requirements Miroslav Angelov European Commission DG Environment, Unit A 1 Enforcement,
Configuration Management and Change Control Change is inevitable! So it has to be planned for and managed.
Business and Information Technology Working Together for the Regulator Stephen Hord, Director of Product Development – UBmatrix.
Firmware - 1 CMS Upgrade Workshop October SLHC CMS Firmware SLHC CMS Firmware Organization, Validation, and Commissioning M. Schulte, University.
CTD Dossier Preparation K. Srikantha Reddy Sr
Topic 4 - Database Design Unit 1 – Database Analysis and Design Advanced Higher Information Systems St Kentigern’s Academy.
1 GLOBAL BIOMETRICS Biostatistics Clinical Data Management Epidemiology & Patient Reported Outcomes Statistical Programming and Analysis Strategic Planning,
SAPRAA 5 Sept 2008 eCTD An overview of the full day presentation by Dr Olaf Schoepke at the SAAPI conference in July 2008.
1 COMMON TECHNICAL DOCUMENT / ORIGIN OF CTD… ICH EWG CTD WAS OFFICIALLY SIGNED OFF IN NOVEMBER 2000, AT 5 TH ICH CONFERENCE; SAN DIEGO,CALIFORNIA.
Accurate  Consistent  Compliant Contact: i4i the structured content company the structured content company.
© CDISC 2015 Paul Houston CDISC Europe Foundation Head of European Operations 1 CTR 2 Protocol Representation Implementation Model Clinical Trial Registration.
DMF Procedures and Communication between API, FFP Manufacturers and Regulatory Authorities Jean-Louis ROBERT National Health Laboratory L – 1011 LUXEMBOURG.
© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 The HL7 RPS and SPL Standards - A High Level View Terry Hardin Sr. IT Architect Emerging Software.
MANAGEMENT INFORMATION SYSTEM
PHC Meeting the global challenge of unique identification of medicinal products SMS, RMS and OMS : Common Terminologies for enabling ISO IDMP.
1 CASE Computer Aided Software Engineering. 2 What is CASE ? A good workshop for any craftsperson has three primary characteristics 1.A collection of.
Division of HIV/AIDS Managing Questionnaire Development for a National HIV Surveillance Survey, Medical Monitoring Project Jennifer L Fagan, Health Scientist/Interview.
ITIL: Service Transition
eHealth Standards and Profiles in Action for Europe and Beyond
Paul Houston CDISC Europe Foundation Head of European Operations
Periodic Safety Update Reports (PSUR)
Chapter 1 The Systems Development Environment
CIM Modeling for E&U - (Short Version)
The Systems Engineering Context
eCTD Lifecycle Gary M Gensinger
Unit 5 Systems Integration and Interoperability
Chapter 1 The Systems Development Environment
Inaugural Expert Council Meeting at E.M.A. London June 25, 2015
Handling ongoing variations concerning same document
Linking persistent identifiers at the British Library
Updated eSubmission Roadmap (v.2.1) Adopted by HMA on
Tools of Software Development
Design and Programming
Machine Independent Features
EU SUBMISSION BY Haripriya & Revathy.
doc.: IEEE <doc#>
TM Workgroup for Electronic Data Interchange.
Software life cycle models
STF-Study tagging file
TM Workgroup for Electronic Data Interchange.
Health Ingenuity Exchange - HingX
doc.: IEEE <doc#>
Detailed Release Note Change Re-baseline UMIG XSDs
Chapter 13 Quality Management
Data Validation in the ESS Context
CVE.
Fundamentals of Electronic Submissions and eCTD
Business View on eCTD v4.0 Advantages and challenges when considering implementation to overcome constrains of the current eCTD specification.
Chapter 11 Describing Process Specifications and Structured Decisions
Detailed Release Note Change Re-baseline UMIG XSDs
Chapter 1 The Systems Development Environment
ESF monitoring and evaluation in Draft guidance
Updated eSubmission Roadmap (v2.2) Adopted by HMA on 21 June 2019
DITA Overview – Build the case for DITA
Interoperability of metadata systems: Follow-up actions
Presentation transcript:

Business Cases and Advantages of eCTD v4.0 Reasons to include its implementation into the Strategic Telematics Roadmap for 2020 - 2025

ICH M8 eCTD v4.0 Orientation Material Advantages of eCTD v4.0 (1) Harmonised submission unit: All content from Module 1 through Module 5 is contained in one exchange message – i.e., an XML file covers both ICH and regional information. Document re-use: Once a document has been submitted, the document may be reused by referencing its unique identifier (ID) from the same or different submission. Allows re-use of meta-data (e.g., document title, language, media type) All the contents of the reused document, including references and hypertext links to other documents, should be relevant to any submission that uses it again. Context of Use life cycle: The Context of Use concept allows for advanced life cycle management operations. A Context of Use may be replaced by one or more Context of Use elements and vice versa (i.e., one to many, many to one) through the context of use life cycle. eCTD v4.0 also introduces the ability to apply changes to keyword definition display name values (e.g., drug substance/product names, manufacturers, dosage forms, indication, excipient, group title) without resubmitting the physical files or the Context of Use element. ICH M8 eCTD v4.0 Orientation Material

ICH M8 eCTD v4.0 Orientation Material Advantages of eCTD v4.0 (2) Function of context of use and keyword combinations: The Context of Use and Keyword combination will function to create a group of documents. It will enable the flexible creation of groups of documents with common links: for example same API, clinical studies or development programmes. Controlled vocabularies (CVs): Allowed values are captured in CVs providing for easier update without the need for system or tool updates. This allows changes due to e.g. new legislation, Brexit, etc. within a time frame of few weeks instead of several months for transition. For sender-defined keyword values, previously submitted values can be corrected/replaced in subsequent submissions Additional document metadata Document metadata may be used to identify submission content (e.g., datasets) that require additional processing ICH M8 eCTD v4.0 Orientation Material

How eCTD 4.0 can Help Regulators Automation of administrative processing Submission of content relevant for more than one dossier / application Implementation of new legal requirements / modification of the dossier structure to adapt better to new business requirements Electronic submission required for regulated product types other than human medicinal products Much less maintenance effort for submission management and reviewing tools Details on each topic will be presented on the following pages…

1. Automation of Administrative Processing Although some improvements of the current eCTD specification are already contributing to an easier automated processing, the situation for grouped submissions of all kinds is laborious to manage and at risk for error. Referencing across applications will reduce workload substantially because technical validation of additional submissionunit.xml files can be automated. Currently, the same content is required to be submitted several times (for example in procedures such as work-sharing, DCP/ MRP). An immediate local benefit of using eCTD 4.0 correctly is that duplicates must no longer be stored in the same national repositories. Even greater benefit will of course be achieved by setting up a common EU “dossier” repository because it would save on the storage overhead for the EU Regulatory Network, and fully enable inter-submission cross-referencing of content. eCTD 4.0 can make it possible to indicate that submitted content has received agency assessment, and what the outcome was. Such information could save further review and assessment work.

3. Grouped Submissions (all kinds of grouping, worksharing, PSUR, ASMF) Example on how to use the same content for more than one dossier Provision of separate submissionunit.xml files of involved applications, submitted in one container to get all information same time The submissionunit.xml will contain contextOfUse elements only for one application and references the document element UUIDs included from e.g. fr1762 submissionunit.xml by which the files are provided No need to store the short life of such a regulatory activity separately No need for additional rules for specific folder names

3. Implementation of New Legal Requirements In the past the adoption of new legal requirements for EU electronic submission content was highly expensive as the eCTD v3.2.2 software code was necessary to be modified resulting in new releases of the DTD, extensive system validation effort and repeated QC of its implementation by all stakeholders. Modification of the dossier structure to adapt better to new business requirements was mostly realised by workarounds or postponed until the next major version of the eCTD publishing/ review tool became available. Any kind of changing the granularity was impossible.

4. Electronic submission required for regulated product types As it was not possible to use the eCTD specification for other than human medicinal products, no one was considering whether and how the messaging standard RPS could have been applied for medical devices, clinical trial applications, veterinary medicinal products and so on. As the presentation of content is completely controlled by the contextOfUse elements defined in a controlled vocabulary, simply the controlled vocabulary needs to be exchanged to adapt the software to the needs of any other product type. The RPS messaging standard fits to all. A common tool, free of use, would allow to use one technical solution for all as well.

5. Maintenance of the software The implement a new version of the specification of eCTD – namely for EU regionally or for m2 to m5 at ICH level – was restricted to very rare occasions as it was very costly and always a complex project activity requiring long planning periods in advance. Following eCTD v4.0 no further maintenance of the software is to be expected. All modification will be executed by adapting the controlled vocabularies instead of updating the software. Following the switch to eCTD v4.0 software and executing the transition all previously submitted content can be used further on. There is no need to re-work the existing structure of local storage.

Forward Compatibility from v3.2. to v4.0 Transition (not a migration) Based on Regulator’s Current View One time transition mapping of IDs Works for eCTD v3.2.2 content, but will not replace a decision on baselining Mapping previous leaf IDs to new contextOfUse IDs will allow further use and re-use in eCTD v4.0 messages No need to modify previously stored sequences or dossiers Principle: eCTD v 4.0 document ID eCTD v3.2.2 Leaf ID Sequence Backbone type

With eCTD v4.0, you can… (for industry) Re-use documents submitted previously, Correct information (e.g. display name or document title) easily, Group documents within a CTD section in a consistent way across ICH regions, Change document granularity while maintaining life cycle relationships, Set the order of documents within a CTD section, Identify submission content (e.g., datasets) for additional processing, and Transition current content in v3.2.2 to v4.0 and continue eCTD life cycle in v4.0. ICH M8 eCTD v4.0 Orientation Material

New Opportunities Compared to v3.2.2 Reduced maintenance efforts as no more software updates are required to address regulatory changes without delay due to the extensive use of controlled vocabularies can achieve this immediately Simplification of life cycle as all activities will be managed by the contextOfUse element Flexibility of dossier granularity and grouping of documents due to priority number and the option of group titles within a section defined by a combination of contextOfUse element and keywords Referencing documents across applications by using the UUID independently from the structure of the storage area at receiver‘s end Two way communication as a future option to exchange information without media breaks and presenting content life cycle consistently at sender‘s and reeceiver‘s end Applicability to all kind of products without the need for software reconfiguration because only a different controlled term list for contexOfUse terms is required

Pre-requisites The benefit-cost-ratio needs to be calculated Agencies which are currently don’t use an eCTD reviewing tool need to implement or need to have access to at least a simple viewing tool Considering that IT developments will move from a document based towards a data based submission an impact analysis how eCTD v4.0 will interact with IDMP implementation, application dataset usage for eAF or product databases for medicinal products.